• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过高分辨率质谱法从卵巢癌腹水中鉴定CA125的方法。

Methods for identification of CA125 from ovarian cancer ascites by high resolution mass spectrometry.

作者信息

Weiland Florian, Fritz Katarina, Oehler Martin K, Hoffmann Peter

机构信息

Adelaide Proteomics Centre, School of Molecular and Biomedical Science, University of Adelaide, Adelaide 5005, Australia.

Research Centre for Reproductive Health, Robinson Institute, University of Adelaide, Adelaide 5005, Australia.

出版信息

Int J Mol Sci. 2012;13(8):9942-9958. doi: 10.3390/ijms13089942. Epub 2012 Aug 9.

DOI:10.3390/ijms13089942
PMID:22949840
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3431838/
Abstract

CA125 is the most widely used tumour marker in ovarian cancer with unsatisfactory sensitivity and specificity especially at early stage. It is quantified by antibody-based immunoassays; however different molecular weight isoforms have been described in the literature which have never been validated by mass spectrometry, potentially affecting the diagnostic accuracy and clinical reliability of the test. In this study, CA125 was detected by Western blot and its identity confirmed by mass spectrometry. Two-dimensional (2D) gel electrophoresis in combination with mass spectrometry revealed that positive Western blot signals up to 500 kDa are most likely false-positive interactions of M11-like and OC125-like antibodies. Fibronectin, identified as one of these false-positive interaction partners, increased the reading for CA125 in a first generation ELISA significantly (p = 0.02). The existence of low-molecular weight isoforms of CA125 is therefore questionable and is most likely reflecting cross-reactivity of the antibodies with other proteins. This would explain the conflicting reports on the molecular structure of CA125 and also the inconsistency of CA125 levels by different ELISAs. Our results are also the first steps towards a mass spectrometric assay for CA125 quantification, which would improve sensitivity and reliability.

摘要

CA125是卵巢癌中使用最广泛的肿瘤标志物,但其敏感性和特异性并不理想,尤其是在疾病早期。它通过基于抗体的免疫测定进行定量;然而,文献中描述了不同分子量的异构体,但从未通过质谱法进行验证,这可能会影响检测的诊断准确性和临床可靠性。在本研究中,通过蛋白质印迹法检测CA125,并通过质谱法确认其身份。二维(2D)凝胶电泳结合质谱分析表明,高达500 kDa的蛋白质印迹阳性信号很可能是M11样抗体和OC125样抗体的假阳性相互作用。纤连蛋白被确定为这些假阳性相互作用伙伴之一,它在第一代酶联免疫吸附测定(ELISA)中显著增加了CA125的读数(p = 0.02)。因此,CA125低分子量异构体的存在值得怀疑,很可能反映了抗体与其他蛋白质的交叉反应。这可以解释关于CA125分子结构的相互矛盾的报道,以及不同ELISA检测CA125水平的不一致性。我们的研究结果也是迈向用于CA125定量的质谱测定法的第一步,这将提高检测的敏感性和可靠性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6b3/3431838/500cb037c340/ijms-13-09942f3a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6b3/3431838/b8bf920de488/ijms-13-09942f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6b3/3431838/396ac95bcfa1/ijms-13-09942f2a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6b3/3431838/500cb037c340/ijms-13-09942f3a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6b3/3431838/b8bf920de488/ijms-13-09942f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6b3/3431838/396ac95bcfa1/ijms-13-09942f2a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6b3/3431838/500cb037c340/ijms-13-09942f3a.jpg

相似文献

1
Methods for identification of CA125 from ovarian cancer ascites by high resolution mass spectrometry.通过高分辨率质谱法从卵巢癌腹水中鉴定CA125的方法。
Int J Mol Sci. 2012;13(8):9942-9958. doi: 10.3390/ijms13089942. Epub 2012 Aug 9.
2
Highly accurate detection of ovarian cancer using CA125 but limited improvement with serum matrix-assisted laser desorption/ionization time-of-flight mass spectrometry profiling.使用 CA125 进行高度准确的卵巢癌检测,但血清基质辅助激光解吸电离飞行时间质谱分析谱图的改善有限。
Int J Gynecol Cancer. 2010 Dec;20(9):1518-24.
3
Haptoglobin-alpha subunit as potential serum biomarker in ovarian cancer: identification and characterization using proteomic profiling and mass spectrometry.触珠蛋白α亚基作为卵巢癌潜在的血清生物标志物:利用蛋白质组分析和质谱法进行鉴定与表征
Clin Cancer Res. 2003 Aug 1;9(8):2904-11.
4
Proteomic biomarkers apolipoprotein A1, truncated transthyretin and connective tissue activating protein III enhance the sensitivity of CA125 for detecting early stage epithelial ovarian cancer.载脂蛋白 A1、截短型转甲状腺素蛋白和结缔组织激活蛋白 III 等蛋白质组生物标志物提高了 CA125 检测早期上皮性卵巢癌的灵敏度。
Gynecol Oncol. 2011 Sep;122(3):548-53. doi: 10.1016/j.ygyno.2011.06.002. Epub 2011 Jun 25.
5
Characterization of serum biomarkers for detection of early stage ovarian cancer.用于检测早期卵巢癌的血清生物标志物的特征分析
Proteomics. 2005 Nov;5(17):4589-96. doi: 10.1002/pmic.200500093.
6
Glycomics analysis of serum: a potential new biomarker for ovarian cancer?血清糖组学分析:卵巢癌潜在的新型生物标志物?
Int J Gynecol Cancer. 2008 May-Jun;18(3):470-5. doi: 10.1111/j.1525-1438.2007.01028.x. Epub 2007 Jul 26.
7
Early detection of ovarian cancer in samples pre-diagnosis using CA125 and MALDI-MS peaks.使用 CA125 和 MALDI-MS 峰在诊断前样本中早期检测卵巢癌。
Cancer Genomics Proteomics. 2011 Nov-Dec;8(6):289-305.
8
Combination of CA125 and RECAF biomarkers for early detection of ovarian cancer.CA125与RECAF生物标志物联合用于卵巢癌的早期检测。
Tumour Biol. 2011 Aug;32(4):831-8. doi: 10.1007/s13277-011-0186-1. Epub 2011 May 28.
9
Developing a mass spectrometry-based assay for the ovarian cancer biomarker CA125 (MUC16) using suspension trapping (STrap).基于悬浮捕获(STrap)技术开发用于卵巢癌生物标志物 CA125(MUC16)的质谱检测法。
Anal Bioanal Chem. 2020 Sep;412(24):6361-6370. doi: 10.1007/s00216-020-02586-9. Epub 2020 Mar 26.
10
Bead-based ELISA for validation of ovarian cancer early detection markers.基于微珠的酶联免疫吸附测定法用于验证卵巢癌早期检测标志物
Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):2117-24. doi: 10.1158/1078-0432.CCR-05-2007.

引用本文的文献

1
Mapping the Binding Sites of CA125-Specific Antibodies on a Revised Molecular Model of MUC16.在修订后的MUC16分子模型上绘制CA125特异性抗体的结合位点。
Cancers (Basel). 2025 Apr 26;17(9):1458. doi: 10.3390/cancers17091458.
2
Enhanced Stability and Sensitivity for CA-125 Detection Under Microfluidic Shear Flow Using Polyethylene Glycol-Coated Biosensor.使用聚乙二醇涂层生物传感器在微流控剪切流下增强CA-125检测的稳定性和灵敏度。
ACS Omega. 2024 Dec 20;10(1):692-702. doi: 10.1021/acsomega.4c07596. eCollection 2025 Jan 14.
3
Polymer-Based Terbium Complex as a Fluorescent Probe for Cancer Antigen 125 Detection: A Promising Tool for Early Diagnosis of Ovarian Cancer.

本文引用的文献

1
In-depth proteomics of ovarian cancer ascites: combining shotgun proteomics and selected reaction monitoring mass spectrometry.卵巢癌腹水的深度蛋白质组学研究:组合型 shotgun 蛋白质组学和选择反应监测质谱法。
J Proteome Res. 2011 May 6;10(5):2286-99. doi: 10.1021/pr1011087. Epub 2011 Apr 14.
2
Conflicting views on the molecular structure of the cancer antigen CA125/MUC16.对癌症抗原 CA125/MUC16 的分子结构存在不同看法。
Dis Markers. 2010;28(6):385-94. doi: 10.3233/DMA-2010-0719.
3
Identification of pregnancy-associated CA125-reactive protein as a carbohydrate-binding immunoglobulin G.
基于聚合物的铽配合物作为癌抗原125检测的荧光探针:一种用于卵巢癌早期诊断的有前景的工具。
ACS Omega. 2024 Jun 1;9(23):24916-24924. doi: 10.1021/acsomega.4c01814. eCollection 2024 Jun 11.
4
A Revised Molecular Model of Ovarian Cancer Biomarker CA125 (MUC16) Enabled by Long-read Sequencing.长读测序技术推动卵巢癌生物标志物 CA125(MUC16)分子模型的修订。
Cancer Res Commun. 2024 Jan 31;4(1):253-263. doi: 10.1158/2767-9764.CRC-23-0327.
5
Selection of Aptamers for Use as Molecular Probes in AFM Detection of Proteins.用于原子力显微镜检测蛋白质的分子探针的适体选择。
Biomolecules. 2023 Dec 12;13(12):1776. doi: 10.3390/biom13121776.
6
Individual recombinant repeats of MUC16 display variable binding to CA125 antibodies.MUC16的各个重组重复序列与CA125抗体的结合具有变异性。
bioRxiv. 2023 Feb 9:2023.02.08.527749. doi: 10.1101/2023.02.08.527749.
7
Molecular Biomarkers for the Early Detection of Ovarian Cancer.用于卵巢癌早期检测的分子生物标志物。
Int J Mol Sci. 2022 Oct 10;23(19):12041. doi: 10.3390/ijms231912041.
8
Diagnostic Value of Preoperative CA125, LDH and HE4 for Leiomyosarcoma of the Female Reproductive System.术前CA125、乳酸脱氢酶和人附睾蛋白4对女性生殖系统平滑肌肉瘤的诊断价值
Cancer Manag Res. 2021 Jun 14;13:4657-4664. doi: 10.2147/CMAR.S302223. eCollection 2021.
9
Leukotriene A Hydrolase Is a Candidate Predictive Biomarker for Successful Allergen Immunotherapy.白三烯 A 水解酶是变应原免疫治疗成功的候选预测性生物标志物。
Front Immunol. 2020 Nov 24;11:559746. doi: 10.3389/fimmu.2020.559746. eCollection 2020.
10
Affinity-free enrichment and mass spectrometry analysis of the ovarian cancer biomarker CA125 (MUC16) from patient-derived ascites.无亲和力富集和质谱分析从患者来源的腹水的卵巢癌生物标志物 CA125(MUC16)。
Analyst. 2021 Jan 4;146(1):85-94. doi: 10.1039/d0an01701a.
鉴定与妊娠相关的 CA125 反应性蛋白为一种碳水化合物结合免疫球蛋白 G。
Arch Biochem Biophys. 2010 Jul;499(1-2):69-76. doi: 10.1016/j.abb.2010.05.011. Epub 2010 May 17.
4
Production and characterization of monoclonal antibodies against the extracellular domain of CA 125.针对 CA 125 细胞外结构域的单克隆抗体的制备与鉴定。
Immunol Invest. 2010 Jan;39(2):114-31. doi: 10.3109/08820130903496785.
5
2-DE with IPGs.使用固定化pH梯度的双向电泳
Electrophoresis. 2009 Jun;30 Suppl 1:S122-32. doi: 10.1002/elps.200900051.
6
Universal sample preparation method for proteome analysis.蛋白质组分析的通用样本制备方法。
Nat Methods. 2009 May;6(5):359-62. doi: 10.1038/nmeth.1322. Epub 2009 Apr 19.
7
Identifying candidate serum biomarkers of exposure to tunicamycins in rats using two-dimensional electrophoresis.利用二维电泳技术鉴定大鼠中暴露于衣霉素的候选血清生物标志物。
J Proteome Res. 2009 Jun;8(6):2812-26. doi: 10.1021/pr801111a.
8
Quantification of thyroglobulin, a low-abundance serum protein, by immunoaffinity peptide enrichment and tandem mass spectrometry.通过免疫亲和肽富集和串联质谱法定量分析甲状腺球蛋白,一种低丰度血清蛋白。
Clin Chem. 2008 Nov;54(11):1796-804. doi: 10.1373/clinchem.2008.109652. Epub 2008 Sep 18.
9
Large scale identification of proteins, mucins, and their O-glycosylation in the endocervical mucus during the menstrual cycle.月经周期中宫颈内膜黏液中蛋白质、黏蛋白及其O-糖基化的大规模鉴定。
Mol Cell Proteomics. 2007 Apr;6(4):708-16. doi: 10.1074/mcp.M600439-MCP200. Epub 2007 Jan 12.
10
Dynamic range of mass accuracy in LTQ Orbitrap hybrid mass spectrometer.LTQ Orbitrap混合质谱仪中质量精度的动态范围。
J Am Soc Mass Spectrom. 2006 Jul;17(7):977-982. doi: 10.1016/j.jasms.2006.03.006. Epub 2006 Jun 5.